Pain Management Market Advancements in non-opioid therapies, AI-integrated solutions, and regenerative <a target=_blank href= ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Bayer's booth presents regenerative agriculture products during the seventh China International Import Expo in Shanghai in November. TANG YANJUN/CHINA NEWS SERVICE Bayer Crop Science, one of the three ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...

In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.

Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...

Despite restructuring efforts, Bayer's financial outlook for 2025 remains weak, with anticipated declining earnings. Consensus estimates project $3-4 billion free cash flow for 2026-2027 ...